CRL vs. ILMN

In the year-to-date period, CRL achieves a -22.95% return, which is significantly lower than ILMN's -1.07% return. Over the past 10 years, CRL has outperformed ILMN with an annualized return of 11.06%, while ILMN has yielded a comparatively lower -3.14% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Illumina, Inc. (ILMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRL Sharpe Ratio is -0.61, which is lower than the ILMN Sharpe Ratio of -0.03. The chart below compares the historical Sharpe Ratios of CRL and ILMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CRL nor ILMN has paid dividends to shareholders.

The maximum CRL drawdown since its inception was -69.81%, smaller than the maximum ILMN drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for CRL and ILMN. For additional features, visit the drawdowns tool.

The current volatility for Charles River Laboratories International, Inc. (CRL) is 9.83%, while Illumina, Inc. (ILMN) has a volatility of 11.23%. This indicates that CRL experiences smaller price fluctuations and is considered to be less risky than ILMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Charles River Laboratories International, Inc. and Illumina, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.